nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—kidney cancer—nephrolithiasis	0.746	1	CtDrD
Doxorubicin—NOS3—nephron—nephrolithiasis	0.00473	0.0588	CbGeAlD
Doxorubicin—SLC22A16—renal system—nephrolithiasis	0.00278	0.0347	CbGeAlD
Doxorubicin—SLC22A16—kidney—nephrolithiasis	0.00269	0.0335	CbGeAlD
Doxorubicin—ABCB8—renal system—nephrolithiasis	0.00217	0.027	CbGeAlD
Doxorubicin—ABCB8—kidney—nephrolithiasis	0.00209	0.0261	CbGeAlD
Doxorubicin—AKR1A1—nephron tubule—nephrolithiasis	0.00177	0.022	CbGeAlD
Doxorubicin—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.00173	0.0227	CcSEcCtD
Doxorubicin—AKR1A1—renal system—nephrolithiasis	0.00161	0.02	CbGeAlD
Doxorubicin—NDUFS7—nephron tubule—nephrolithiasis	0.00161	0.02	CbGeAlD
Doxorubicin—AKR1A1—kidney—nephrolithiasis	0.00156	0.0194	CbGeAlD
Doxorubicin—AKR1A1—cortex of kidney—nephrolithiasis	0.00152	0.0189	CbGeAlD
Doxorubicin—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00148	0.0194	CcSEcCtD
Doxorubicin—NDUFS7—renal system—nephrolithiasis	0.00146	0.0182	CbGeAlD
Doxorubicin—NDUFS7—kidney—nephrolithiasis	0.00141	0.0176	CbGeAlD
Doxorubicin—NDUFS7—cortex of kidney—nephrolithiasis	0.00138	0.0171	CbGeAlD
Doxorubicin—AURKA—renal system—nephrolithiasis	0.00136	0.0169	CbGeAlD
Doxorubicin—NDUFS2—nephron tubule—nephrolithiasis	0.00133	0.0166	CbGeAlD
Doxorubicin—NDUFS3—nephron tubule—nephrolithiasis	0.00132	0.0164	CbGeAlD
Doxorubicin—AURKA—kidney—nephrolithiasis	0.00131	0.0164	CbGeAlD
Doxorubicin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.00126	0.0166	CcSEcCtD
Doxorubicin—DHCR7—nephron tubule—nephrolithiasis	0.00125	0.0156	CbGeAlD
Doxorubicin—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00123	0.0161	CcSEcCtD
Doxorubicin—NOS1—renal system—nephrolithiasis	0.00122	0.0152	CbGeAlD
Doxorubicin—NDUFS2—renal system—nephrolithiasis	0.00121	0.0151	CbGeAlD
Doxorubicin—NDUFS3—renal system—nephrolithiasis	0.0012	0.0149	CbGeAlD
Doxorubicin—NOS1—kidney—nephrolithiasis	0.00118	0.0147	CbGeAlD
Doxorubicin—NDUFS2—kidney—nephrolithiasis	0.00117	0.0146	CbGeAlD
Doxorubicin—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0152	CcSEcCtD
Doxorubicin—NDUFS3—kidney—nephrolithiasis	0.00116	0.0144	CbGeAlD
Doxorubicin—NOS1—cortex of kidney—nephrolithiasis	0.00115	0.0143	CbGeAlD
Doxorubicin—NDUFS2—cortex of kidney—nephrolithiasis	0.00114	0.0142	CbGeAlD
Doxorubicin—NDUFS3—cortex of kidney—nephrolithiasis	0.00113	0.014	CbGeAlD
Doxorubicin—Stinging—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0148	CcSEcCtD
Doxorubicin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00112	0.0148	CcSEcCtD
Doxorubicin—ABCC6—renal system—nephrolithiasis	0.00111	0.0138	CbGeAlD
Doxorubicin—ABCC6—kidney—nephrolithiasis	0.00107	0.0133	CbGeAlD
Doxorubicin—DHCR7—cortex of kidney—nephrolithiasis	0.00107	0.0133	CbGeAlD
Doxorubicin—CYP3A4—urine—nephrolithiasis	0.00105	0.0131	CbGeAlD
Doxorubicin—YWHAG—renal system—nephrolithiasis	0.00104	0.013	CbGeAlD
Doxorubicin—RALBP1—nephron tubule—nephrolithiasis	0.00104	0.0129	CbGeAlD
Doxorubicin—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00104	0.0136	CcSEcCtD
Doxorubicin—CYP2D6—urine—nephrolithiasis	0.00103	0.0129	CbGeAlD
Doxorubicin—XDH—renal system—nephrolithiasis	0.00102	0.0127	CbGeAlD
Doxorubicin—YWHAG—kidney—nephrolithiasis	0.00101	0.0126	CbGeAlD
Doxorubicin—XDH—kidney—nephrolithiasis	0.000984	0.0123	CbGeAlD
Doxorubicin—YWHAG—cortex of kidney—nephrolithiasis	0.000983	0.0122	CbGeAlD
Doxorubicin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00098	0.0129	CcSEcCtD
Doxorubicin—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00098	0.0129	CcSEcCtD
Doxorubicin—CBR1—nephron tubule—nephrolithiasis	0.000968	0.0121	CbGeAlD
Doxorubicin—AKR1C3—nephron tubule—nephrolithiasis	0.000956	0.0119	CbGeAlD
Doxorubicin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.000949	0.0125	CcSEcCtD
Doxorubicin—RALBP1—renal system—nephrolithiasis	0.000943	0.0117	CbGeAlD
Doxorubicin—NOS3—renal system—nephrolithiasis	0.000927	0.0115	CbGeAlD
Doxorubicin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.000926	0.0122	CcSEcCtD
Doxorubicin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.000926	0.0122	CcSEcCtD
Doxorubicin—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.000921	0.0121	CcSEcCtD
Doxorubicin—RALBP1—kidney—nephrolithiasis	0.000911	0.0113	CbGeAlD
Doxorubicin—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00091	0.012	CcSEcCtD
Doxorubicin—NOS3—kidney—nephrolithiasis	0.000896	0.0112	CbGeAlD
Doxorubicin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.000894	0.0117	CcSEcCtD
Doxorubicin—RALBP1—cortex of kidney—nephrolithiasis	0.000887	0.0111	CbGeAlD
Doxorubicin—CBR1—renal system—nephrolithiasis	0.00088	0.011	CbGeAlD
Doxorubicin—POR—nephron tubule—nephrolithiasis	0.000873	0.0109	CbGeAlD
Doxorubicin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.000859	0.0113	CcSEcCtD
Doxorubicin—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.000854	0.0112	CcSEcCtD
Doxorubicin—CBR1—kidney—nephrolithiasis	0.000851	0.0106	CbGeAlD
Doxorubicin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.000831	0.0109	CcSEcCtD
Doxorubicin—CBR1—cortex of kidney—nephrolithiasis	0.000828	0.0103	CbGeAlD
Doxorubicin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.000822	0.0108	CcSEcCtD
Doxorubicin—AKR1C3—cortex of kidney—nephrolithiasis	0.000818	0.0102	CbGeAlD
Doxorubicin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00081	0.0106	CcSEcCtD
Doxorubicin—NQO1—nephron tubule—nephrolithiasis	0.000776	0.00966	CbGeAlD
Doxorubicin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.000759	0.00997	CcSEcCtD
Doxorubicin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.000752	0.00988	CcSEcCtD
Doxorubicin—POR—cortex of kidney—nephrolithiasis	0.000747	0.0093	CbGeAlD
Doxorubicin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.000738	0.0097	CcSEcCtD
Doxorubicin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.000706	0.00927	CcSEcCtD
Doxorubicin—NQO1—renal system—nephrolithiasis	0.000705	0.00878	CbGeAlD
Doxorubicin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.000703	0.00923	CcSEcCtD
Doxorubicin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0007	0.00919	CcSEcCtD
Doxorubicin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.0007	0.00919	CcSEcCtD
Doxorubicin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.000694	0.00912	CcSEcCtD
Doxorubicin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.000685	0.009	CcSEcCtD
Doxorubicin—NQO1—kidney—nephrolithiasis	0.000682	0.00849	CbGeAlD
Doxorubicin—NQO1—cortex of kidney—nephrolithiasis	0.000664	0.00827	CbGeAlD
Doxorubicin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.000663	0.00871	CcSEcCtD
Doxorubicin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00066	0.00868	CcSEcCtD
Doxorubicin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00066	0.00868	CcSEcCtD
Doxorubicin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00065	0.00854	CcSEcCtD
Doxorubicin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00065	0.00854	CcSEcCtD
Doxorubicin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.000637	0.00838	CcSEcCtD
Doxorubicin—ABCC3—renal system—nephrolithiasis	0.000633	0.00788	CbGeAlD
Doxorubicin—ABCC10—renal system—nephrolithiasis	0.00063	0.00784	CbGeAlD
Doxorubicin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00822	CcSEcCtD
Doxorubicin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.000621	0.00816	CcSEcCtD
Doxorubicin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.000618	0.00813	CcSEcCtD
Doxorubicin—NQO1—Amino acid and derivative metabolism—GRHPR—nephrolithiasis	0.000617	0.00634	CbGpPWpGaD
Doxorubicin—ABCC3—kidney—nephrolithiasis	0.000612	0.00762	CbGeAlD
Doxorubicin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00061	0.00801	CcSEcCtD
Doxorubicin—ABCC10—kidney—nephrolithiasis	0.000609	0.00758	CbGeAlD
Doxorubicin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.000605	0.00795	CcSEcCtD
Doxorubicin—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.000603	0.00792	CcSEcCtD
Doxorubicin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.000603	0.00792	CcSEcCtD
Doxorubicin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.000601	0.0079	CcSEcCtD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000598	0.00614	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000598	0.00614	CbGpPWpGaD
Doxorubicin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.000597	0.00784	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.000594	0.00781	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000594	0.00781	CcSEcCtD
Doxorubicin—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.000593	0.0061	CbGpPWpGaD
Doxorubicin—ABCC10—cortex of kidney—nephrolithiasis	0.000593	0.00738	CbGeAlD
Doxorubicin—NOS3—Myometrial Relaxation and Contraction Pathways—RGS14—nephrolithiasis	0.000587	0.00603	CbGpPWpGaD
Doxorubicin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.000584	0.00768	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.000582	0.00765	CcSEcCtD
Doxorubicin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.000582	0.00765	CcSEcCtD
Doxorubicin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.000574	0.00755	CcSEcCtD
Doxorubicin—NQO1—NRF2 pathway—SLC2A9—nephrolithiasis	0.000572	0.00588	CbGpPWpGaD
Doxorubicin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.000571	0.0075	CcSEcCtD
Doxorubicin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.000571	0.0075	CcSEcCtD
Doxorubicin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.000559	0.00735	CcSEcCtD
Doxorubicin—ABCC2—nephron tubule—nephrolithiasis	0.000556	0.00693	CbGeAlD
Doxorubicin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.000556	0.0073	CcSEcCtD
Doxorubicin—NQO1—Amino acid and derivative metabolism—AGXT—nephrolithiasis	0.00055	0.00565	CbGpPWpGaD
Doxorubicin—CYP1B1—nephron tubule—nephrolithiasis	0.000545	0.00678	CbGeAlD
Doxorubicin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.000534	0.00701	CcSEcCtD
Doxorubicin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.000534	0.00701	CcSEcCtD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000533	0.00548	CbGpPWpGaD
Doxorubicin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00053	0.00697	CcSEcCtD
Doxorubicin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.000527	0.00693	CcSEcCtD
Doxorubicin—ABCB8—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000522	0.00537	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000522	0.00537	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000522	0.00537	CbGpPWpGaD
Doxorubicin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.000521	0.00684	CcSEcCtD
Doxorubicin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.000519	0.00682	CcSEcCtD
Doxorubicin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.000515	0.00676	CcSEcCtD
Doxorubicin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.000512	0.00672	CcSEcCtD
Doxorubicin—NOS2—Spinal Cord Injury—AQP1—nephrolithiasis	0.000508	0.00522	CbGpPWpGaD
Doxorubicin—ABCC2—renal system—nephrolithiasis	0.000506	0.0063	CbGeAlD
Doxorubicin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.000504	0.00663	CcSEcCtD
Doxorubicin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0005	0.00657	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.000499	0.00655	CcSEcCtD
Doxorubicin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.000496	0.00652	CcSEcCtD
Doxorubicin—CYP1B1—renal system—nephrolithiasis	0.000495	0.00617	CbGeAlD
Doxorubicin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.000495	0.0065	CcSEcCtD
Doxorubicin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.000495	0.0065	CcSEcCtD
Doxorubicin—ABCC2—kidney—nephrolithiasis	0.000489	0.00609	CbGeAlD
Doxorubicin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.000488	0.00641	CcSEcCtD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000487	0.00501	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000487	0.00501	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000487	0.00501	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000487	0.00501	CbGpPWpGaD
Doxorubicin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.000485	0.00637	CcSEcCtD
Doxorubicin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00048	0.00631	CcSEcCtD
Doxorubicin—CYP1B1—kidney—nephrolithiasis	0.000479	0.00596	CbGeAlD
Doxorubicin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.000477	0.00627	CcSEcCtD
Doxorubicin—ABCC2—cortex of kidney—nephrolithiasis	0.000476	0.00593	CbGeAlD
Doxorubicin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.000475	0.00624	CcSEcCtD
Doxorubicin—CYP1B1—cortex of kidney—nephrolithiasis	0.000466	0.0058	CbGeAlD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000466	0.00479	CbGpPWpGaD
Doxorubicin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.000465	0.00611	CcSEcCtD
Doxorubicin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.000458	0.00602	CcSEcCtD
Doxorubicin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.000457	0.006	CcSEcCtD
Doxorubicin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.000454	0.00597	CcSEcCtD
Doxorubicin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.000453	0.00596	CcSEcCtD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000453	0.00466	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000453	0.00466	CbGpPWpGaD
Doxorubicin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00045	0.00591	CcSEcCtD
Doxorubicin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00044	0.00578	CcSEcCtD
Doxorubicin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.000432	0.00567	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000426	0.00438	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000426	0.00438	CbGpPWpGaD
Doxorubicin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000426	0.0056	CcSEcCtD
Doxorubicin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000424	0.00557	CcSEcCtD
Doxorubicin—ABCC1—cortex of kidney—nephrolithiasis	0.000419	0.00522	CbGeAlD
Doxorubicin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000408	0.00536	CcSEcCtD
Doxorubicin—ABCG2—nephron tubule—nephrolithiasis	0.000406	0.00505	CbGeAlD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000404	0.00415	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000404	0.00415	CbGpPWpGaD
Doxorubicin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000404	0.0053	CcSEcCtD
Doxorubicin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.000398	0.00522	CcSEcCtD
Doxorubicin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.000392	0.00515	CcSEcCtD
Doxorubicin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00039	0.00513	CcSEcCtD
Doxorubicin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000389	0.00512	CcSEcCtD
Doxorubicin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000386	0.00507	CcSEcCtD
Doxorubicin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.000385	0.00505	CcSEcCtD
Doxorubicin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.000382	0.00502	CcSEcCtD
Doxorubicin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.000375	0.00492	CcSEcCtD
Doxorubicin—CYP2B6—nephron tubule—nephrolithiasis	0.000374	0.00466	CbGeAlD
Doxorubicin—YWHAG—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000372	0.00383	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000369	0.0038	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000369	0.0038	CbGpPWpGaD
Doxorubicin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000369	0.00485	CcSEcCtD
Doxorubicin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.000367	0.00483	CcSEcCtD
Doxorubicin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000365	0.0048	CcSEcCtD
Doxorubicin—ABCC3—NRF2 pathway—SLC2A9—nephrolithiasis	0.000363	0.00373	CbGpPWpGaD
Doxorubicin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000359	0.00471	CcSEcCtD
Doxorubicin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.000357	0.00469	CcSEcCtD
Doxorubicin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000357	0.00469	CcSEcCtD
Doxorubicin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000356	0.00468	CcSEcCtD
Doxorubicin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000351	0.00462	CcSEcCtD
Doxorubicin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000349	0.00459	CcSEcCtD
Doxorubicin—Cough—Hydrochlorothiazide—nephrolithiasis	0.000347	0.00456	CcSEcCtD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000343	0.00353	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000343	0.00353	CbGpPWpGaD
Doxorubicin—CYP2B6—renal system—nephrolithiasis	0.00034	0.00424	CbGeAlD
Doxorubicin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.000338	0.00445	CcSEcCtD
Doxorubicin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.000338	0.00445	CcSEcCtD
Doxorubicin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.000338	0.00445	CcSEcCtD
Doxorubicin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000337	0.00443	CcSEcCtD
Doxorubicin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.000334	0.00439	CcSEcCtD
Doxorubicin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000331	0.00435	CcSEcCtD
Doxorubicin—CYP2B6—kidney—nephrolithiasis	0.000329	0.00409	CbGeAlD
Doxorubicin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000327	0.0043	CcSEcCtD
Doxorubicin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000324	0.00426	CcSEcCtD
Doxorubicin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000324	0.00426	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000323	0.00332	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000323	0.00332	CbGpPWpGaD
Doxorubicin—SLC22A16—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000323	0.00332	CbGpPWpGaD
Doxorubicin—Shock—Hydrochlorothiazide—nephrolithiasis	0.000319	0.0042	CcSEcCtD
Doxorubicin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000318	0.00418	CcSEcCtD
Doxorubicin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000317	0.00416	CcSEcCtD
Doxorubicin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000314	0.00412	CcSEcCtD
Doxorubicin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000309	0.00406	CcSEcCtD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000306	0.00315	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000306	0.00315	CbGpPWpGaD
Doxorubicin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.000303	0.00398	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.0003	0.00308	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.0003	0.00308	CbGpPWpGaD
Doxorubicin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.000296	0.00389	CcSEcCtD
Doxorubicin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.000293	0.00386	CcSEcCtD
Doxorubicin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000291	0.00383	CcSEcCtD
Doxorubicin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.000289	0.0038	CcSEcCtD
Doxorubicin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000288	0.00379	CcSEcCtD
Doxorubicin—ABCC2—NRF2 pathway—SLC2A9—nephrolithiasis	0.000288	0.00296	CbGpPWpGaD
Doxorubicin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000286	0.00375	CcSEcCtD
Doxorubicin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000282	0.00371	CcSEcCtD
Doxorubicin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00028	0.00368	CcSEcCtD
Doxorubicin—Pain—Hydrochlorothiazide—nephrolithiasis	0.000277	0.00365	CcSEcCtD
Doxorubicin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000277	0.00365	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000267	0.00275	CbGpPWpGaD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000267	0.00275	CbGpPWpGaD
Doxorubicin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000267	0.00351	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000265	0.00349	CcSEcCtD
Doxorubicin—NOS1—Hemostasis—DGKH—nephrolithiasis	0.000263	0.0027	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—SLC7A9—nephrolithiasis	0.000263	0.0027	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—GRHPR—nephrolithiasis	0.00026	0.00268	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—GRHPR—nephrolithiasis	0.00026	0.00268	CbGpPWpGaD
Doxorubicin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000258	0.00339	CcSEcCtD
Doxorubicin—CYP3A4—renal system—nephrolithiasis	0.000257	0.0032	CbGeAlD
Doxorubicin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000257	0.00337	CcSEcCtD
Doxorubicin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000257	0.00337	CcSEcCtD
Doxorubicin—CYP2D6—renal system—nephrolithiasis	0.000253	0.00315	CbGeAlD
Doxorubicin—CYP3A4—kidney—nephrolithiasis	0.000248	0.00309	CbGeAlD
Doxorubicin—NDUFS2—Metabolism—GRHPR—nephrolithiasis	0.000245	0.00252	CbGpPWpGaD
Doxorubicin—ABCC6—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000245	0.00251	CbGpPWpGaD
Doxorubicin—CYP2D6—kidney—nephrolithiasis	0.000244	0.00304	CbGeAlD
Doxorubicin—CYP1B1—Biological oxidations—SLC26A1—nephrolithiasis	0.000241	0.00248	CbGpPWpGaD
Doxorubicin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.000239	0.00314	CcSEcCtD
Doxorubicin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000233	0.00306	CcSEcCtD
Doxorubicin—NDUFS3—Metabolism—AGXT—nephrolithiasis	0.000232	0.00238	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AGXT—nephrolithiasis	0.000232	0.00238	CbGpPWpGaD
Doxorubicin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00023	0.00302	CcSEcCtD
Doxorubicin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000222	0.00292	CcSEcCtD
Doxorubicin—NDUFS2—Metabolism—AGXT—nephrolithiasis	0.000218	0.00224	CbGpPWpGaD
Doxorubicin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000215	0.00282	CcSEcCtD
Doxorubicin—ABCC10—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000214	0.0022	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—GRHPR—nephrolithiasis	0.000208	0.00214	CbGpPWpGaD
Doxorubicin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000206	0.00271	CcSEcCtD
Doxorubicin—Rash—Hydrochlorothiazide—nephrolithiasis	0.000205	0.00269	CcSEcCtD
Doxorubicin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000204	0.00269	CcSEcCtD
Doxorubicin—Headache—Hydrochlorothiazide—nephrolithiasis	0.000203	0.00267	CcSEcCtD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000202	0.00208	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000202	0.00208	CbGpPWpGaD
Doxorubicin—ABCB1—nephron tubule—nephrolithiasis	0.0002	0.00249	CbGeAlD
Doxorubicin—NOS2—Hemostasis—SLC7A9—nephrolithiasis	0.000198	0.00204	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—DGKH—nephrolithiasis	0.000198	0.00204	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—APRT—nephrolithiasis	0.000197	0.00203	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—SLC26A1—nephrolithiasis	0.000197	0.00203	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—SLC26A1—nephrolithiasis	0.000197	0.00203	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—APRT—nephrolithiasis	0.000197	0.00203	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—GRHPR—nephrolithiasis	0.000194	0.00199	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ADCY10—nephrolithiasis	0.000194	0.00199	CbGpPWpGaD
Doxorubicin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000193	0.00253	CcSEcCtD
Doxorubicin—NDUFS2—Metabolism—SLC26A1—nephrolithiasis	0.000185	0.00191	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AGXT—nephrolithiasis	0.000185	0.00191	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—APRT—nephrolithiasis	0.000185	0.00191	CbGpPWpGaD
Doxorubicin—ABCB1—renal system—nephrolithiasis	0.000182	0.00226	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00018	0.00185	CbGpPWpGaD
Doxorubicin—ABCB1—kidney—nephrolithiasis	0.000176	0.00219	CbGeAlD
Doxorubicin—CBR1—Metabolism—AGXT—nephrolithiasis	0.000173	0.00178	CbGpPWpGaD
Doxorubicin—ABCB1—cortex of kidney—nephrolithiasis	0.000171	0.00213	CbGeAlD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000165	0.0017	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000165	0.0017	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RGS14—nephrolithiasis	0.000165	0.0017	CbGpPWpGaD
Doxorubicin—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.000161	0.00165	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00016	0.00165	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00016	0.00165	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000159	0.00163	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000159	0.00163	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—APRT—nephrolithiasis	0.000158	0.00162	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—SLC26A1—nephrolithiasis	0.000158	0.00162	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—SLC7A9—nephrolithiasis	0.000154	0.00158	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—DGKH—nephrolithiasis	0.000154	0.00158	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—SLC26A1—nephrolithiasis	0.000147	0.00151	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—APRT—nephrolithiasis	0.000147	0.00151	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000143	0.00147	CbGpPWpGaD
Doxorubicin—NOS1—Disease—SLC26A1—nephrolithiasis	0.000143	0.00147	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000141	0.00145	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AQP1—nephrolithiasis	0.000141	0.00144	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AQP1—nephrolithiasis	0.000141	0.00144	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000139	0.00143	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000139	0.00143	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AQP1—nephrolithiasis	0.000132	0.00136	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000131	0.00134	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000131	0.00134	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000129	0.00133	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000129	0.00133	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ATP6V0A4—nephrolithiasis	0.000127	0.00131	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—CHRM3—nephrolithiasis	0.000127	0.00131	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—CHRM3—nephrolithiasis	0.000127	0.00131	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000125	0.00129	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000125	0.00129	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000124	0.00128	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—CHRM3—nephrolithiasis	0.000119	0.00123	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000116	0.00119	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000116	0.00119	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000114	0.00117	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000114	0.00117	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GRHPR—nephrolithiasis	0.000113	0.00116	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AQP1—nephrolithiasis	0.000112	0.00116	CbGpPWpGaD
Doxorubicin—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000112	0.00115	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000111	0.00115	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—DGKH—nephrolithiasis	0.000111	0.00115	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GRHPR—nephrolithiasis	0.000109	0.00112	CbGpPWpGaD
Doxorubicin—NOS2—Disease—SLC26A1—nephrolithiasis	0.000108	0.00111	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ADCY10—nephrolithiasis	0.000107	0.00111	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AQP1—nephrolithiasis	0.000105	0.00108	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000104	0.00106	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000104	0.00106	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—CHRM3—nephrolithiasis	0.000102	0.00104	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GRHPR—nephrolithiasis	0.000102	0.00104	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AGXT—nephrolithiasis	0.000101	0.00104	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	9.91e-05	0.00102	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	9.91e-05	0.00102	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—SLC26A1—nephrolithiasis	9.89e-05	0.00102	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	9.79e-05	0.00101	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	9.79e-05	0.00101	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AGXT—nephrolithiasis	9.74e-05	0.001	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ATP6V0A4—nephrolithiasis	9.59e-05	0.000986	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—CHRM3—nephrolithiasis	9.48e-05	0.000974	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GRHPR—nephrolithiasis	9.23e-05	0.000949	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.21e-05	0.000947	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.21e-05	0.000947	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RGS14—nephrolithiasis	9.14e-05	0.00094	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	9.1e-05	0.000936	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	9.1e-05	0.000936	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ADCY10—nephrolithiasis	9.08e-05	0.000934	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AGXT—nephrolithiasis	9.06e-05	0.000931	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ATP6V0A4—nephrolithiasis	8.81e-05	0.000906	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	8.62e-05	0.000886	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	8.62e-05	0.000886	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—APRT—nephrolithiasis	8.58e-05	0.000883	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—SLC26A1—nephrolithiasis	8.58e-05	0.000883	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SLC26A1—nephrolithiasis	8.36e-05	0.000859	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—SLC26A1—nephrolithiasis	8.28e-05	0.000852	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—APRT—nephrolithiasis	8.28e-05	0.000852	CbGpPWpGaD
Doxorubicin—ABCC3—Transmembrane transport of small molecules—AQP1—nephrolithiasis	8.28e-05	0.000851	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AGXT—nephrolithiasis	8.23e-05	0.000846	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.21e-05	0.000844	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.21e-05	0.000844	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	8.12e-05	0.000834	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	8.12e-05	0.000834	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CHRM3—nephrolithiasis	8.05e-05	0.000828	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	8.01e-05	0.000824	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	8.01e-05	0.000824	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RGS14—nephrolithiasis	7.72e-05	0.000794	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—SLC26A1—nephrolithiasis	7.7e-05	0.000792	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—APRT—nephrolithiasis	7.7e-05	0.000792	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	7.54e-05	0.000775	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	7.54e-05	0.000775	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GRHPR—nephrolithiasis	7.49e-05	0.00077	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ATP6V0A4—nephrolithiasis	7.45e-05	0.000766	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PTH—nephrolithiasis	7.37e-05	0.000757	CbGpPWpGaD
Doxorubicin—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	7.31e-05	0.000751	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GRHPR—nephrolithiasis	7.18e-05	0.000738	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	7.14e-05	0.000734	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	7.14e-05	0.000734	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—APRT—nephrolithiasis	7e-05	0.00072	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—SLC26A1—nephrolithiasis	7e-05	0.00072	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	6.72e-05	0.000691	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AGXT—nephrolithiasis	6.68e-05	0.000686	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.56e-05	0.000675	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	6.49e-05	0.000667	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AGXT—nephrolithiasis	6.4e-05	0.000658	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ATP6V0A4—nephrolithiasis	6.17e-05	0.000635	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DGKH—nephrolithiasis	6.17e-05	0.000635	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	6.15e-05	0.000632	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	6.15e-05	0.000632	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AQP1—nephrolithiasis	6.12e-05	0.000629	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AQP1—nephrolithiasis	5.9e-05	0.000607	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	5.71e-05	0.000587	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—SLC26A1—nephrolithiasis	5.68e-05	0.000584	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—APRT—nephrolithiasis	5.68e-05	0.000584	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GRHPR—nephrolithiasis	5.63e-05	0.000579	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—CHRM3—nephrolithiasis	5.53e-05	0.000569	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AQP1—nephrolithiasis	5.49e-05	0.000564	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GRHPR—nephrolithiasis	5.44e-05	0.00056	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—APRT—nephrolithiasis	5.44e-05	0.00056	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—SLC26A1—nephrolithiasis	5.44e-05	0.00056	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—CHRM3—nephrolithiasis	5.34e-05	0.000549	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.22e-05	0.000536	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DGKH—nephrolithiasis	5.22e-05	0.000536	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SLC26A1—nephrolithiasis	5.09e-05	0.000524	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AGXT—nephrolithiasis	5.02e-05	0.000516	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AQP1—nephrolithiasis	4.99e-05	0.000513	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—CHRM3—nephrolithiasis	4.96e-05	0.00051	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GRHPR—nephrolithiasis	4.95e-05	0.000509	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AGXT—nephrolithiasis	4.85e-05	0.000499	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	4.66e-05	0.000479	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	4.66e-05	0.000479	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ATP6V0A4—nephrolithiasis	4.54e-05	0.000467	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—CHRM3—nephrolithiasis	4.51e-05	0.000464	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CHRM3—nephrolithiasis	4.46e-05	0.000459	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AGXT—nephrolithiasis	4.41e-05	0.000454	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	4.33e-05	0.000445	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	4.33e-05	0.000445	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—APRT—nephrolithiasis	4.26e-05	0.000438	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—SLC26A1—nephrolithiasis	4.26e-05	0.000438	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—SLC26A1—nephrolithiasis	4.12e-05	0.000424	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—APRT—nephrolithiasis	4.12e-05	0.000424	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTH—nephrolithiasis	4.08e-05	0.00042	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AQP1—nephrolithiasis	4.04e-05	0.000416	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AQP1—nephrolithiasis	3.88e-05	0.000399	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	3.86e-05	0.000397	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	3.86e-05	0.000397	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CHRM3—nephrolithiasis	3.77e-05	0.000388	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—APRT—nephrolithiasis	3.75e-05	0.000386	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—SLC26A1—nephrolithiasis	3.75e-05	0.000386	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SPP1—nephrolithiasis	3.7e-05	0.00038	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—CHRM3—nephrolithiasis	3.66e-05	0.000376	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GRHPR—nephrolithiasis	3.63e-05	0.000373	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—CHRM3—nephrolithiasis	3.51e-05	0.000361	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTH—nephrolithiasis	3.45e-05	0.000355	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AGXT—nephrolithiasis	3.23e-05	0.000333	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	3.09e-05	0.000317	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AQP1—nephrolithiasis	3.04e-05	0.000312	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AQP1—nephrolithiasis	2.94e-05	0.000302	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	2.75e-05	0.000283	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—APRT—nephrolithiasis	2.75e-05	0.000283	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CHRM3—nephrolithiasis	2.75e-05	0.000283	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GRHPR—nephrolithiasis	2.68e-05	0.000275	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AQP1—nephrolithiasis	2.67e-05	0.000275	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CHRM3—nephrolithiasis	2.66e-05	0.000273	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GRHPR—nephrolithiasis	2.52e-05	0.000259	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CHRM3—nephrolithiasis	2.42e-05	0.000249	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AGXT—nephrolithiasis	2.39e-05	0.000245	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AGXT—nephrolithiasis	2.25e-05	0.000231	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—nephrolithiasis	2.05e-05	0.000211	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—APRT—nephrolithiasis	2.03e-05	0.000209	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—SLC26A1—nephrolithiasis	2.03e-05	0.000209	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AQP1—nephrolithiasis	1.96e-05	0.000202	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	1.91e-05	0.000197	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—APRT—nephrolithiasis	1.91e-05	0.000197	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CHRM3—nephrolithiasis	1.77e-05	0.000182	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—nephrolithiasis	1.73e-05	0.000178	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GRHPR—nephrolithiasis	1.65e-05	0.00017	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AGXT—nephrolithiasis	1.47e-05	0.000151	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AQP1—nephrolithiasis	1.45e-05	0.000149	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AQP1—nephrolithiasis	1.36e-05	0.00014	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CHRM3—nephrolithiasis	1.31e-05	0.000134	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.25e-05	0.000129	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—APRT—nephrolithiasis	1.25e-05	0.000129	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.23e-05	0.000127	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AQP1—nephrolithiasis	8.91e-06	9.16e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CHRM3—nephrolithiasis	8.05e-06	8.28e-05	CbGpPWpGaD
